Cognitive Behavior Therapy [CBT]
Cognitive Behavior Therapy [CBT] and Cognitive Enhancement Therapy tend to be the among the only treatments for depression, schizophrenia, and various forms of “mental illness” that address the underlying issues of brain cell loss.
Arguably “mental illness” is due to brain cell loss.
The drug approach focuses on neurotransmitters, ignoring the loss of brain cells that produce the neurotransmitters.
National Association Of Cognitive Behavioral Therapy [CBT]
http://www.nacbt.org/
—– find a CBT practitioner in your area
http://www.nacbt.org/find-a-therapist/
—– Online counseling in Cognitive Behavioral Therapy
http://www.nacbt.org/cbt-online-cognitive-behavioral-therapy-from-a-certified-cognitive-behavioral-therapist/
.
.
“Depression is one of the most prevalent and debilitating of the psychiatric disorders. Studies have shown that cognitive therapy is as efficacious as antidepressant medications at treating depression, and it seems to reduce the risk of relapse even after its discontinuation.”
.
R.J.DeRubeis
Cognitive therapy vs. medications for depression: Treatment outcomes and neural mechanisms
Nature Reviews Neuroscience…..Volume 9 #10….October 2008….page 788 – 796
———————————————
“Many studies have confirmed the efficacy of cognitive behavioral therapy (CBT) as a treatment for depression. This study explored the mechanism of cognitive behavioral therapy from the perspective of individuals’ problem-solving appraisal.”
“Findings supported the research hypothesis that the more individuals improved their problem-solving appraisal, the more their depression decreased.”
“Additionally, it was discovered that the poorer individuals’ problem-solving appraisal before the cognitive behavioral therapy, the more improvement they had on depression and problem solving appraisal after the cognitive behavioral therapy.”
“In sum, findings suggested that problem-solving appraisal might play an important part in cognitive behavioral therapy for depression reduction…..”
Szu.Y.Chen et al
The Effect of Cognitive Behavioral Therapy (CBT) on Depression: The Role of Problem-Solving Appraisal
Research on Social Work Practice……Volume 16 #5……September 2006…..page 500 – 510
———————————————
“The evidence base for cognitive behavioral therapy (CBT) for depression is discussed…….identifies the need to deliver evidence-based psychosocial interventions and identifies cognitive behavioral therapy as having the strongest research base for effectiveness….”
G.Whitefield, et al
The evidence base for cognitive–behavioural therapy in depression: delivery in busy clinical settings
Advances in Psychiatric Treatment….Volume 9….2003…..page 21 – 30
————————————————–
“Cognitive rehabilitation has shown efficacy in improving cognition in patients with schizophrenia….”
“…..examine differential changes in brain morphology in early course schizophrenia during cognitive rehabilitation vs supportive therapy”
“A 2-year trial with annual structural magnetic resonance imaging and cognitive assessments.”
“Cognitive enhancement therapy is an integrated approach to the remediation of cognitive impairment in schizophrenia that uses computer-assisted neurocognitive training and group-based social-cognitive exercises.”
“Patients who received cognitive enhancement therapy demonstrated significantly greater preservation of gray matter volume over 2 years in the left hippocampus, parahippocampal gyrus, and fusiform gyrus, and significantly greater gray matter increases in the left amygdala….”
“Less gray matter loss in the left parahippocampal and fusiform gyrus and greater gray matter increases in the left amygdala were significantly related to improved cognition and mediated the beneficial cognitive effects of cognitive enhancement therapy.”
“Cognitive enhancement therapy may offer neurobiologic protective and enhancing effects in early schizophrenia that are associated with improved long-term cognitive outcomes.”
S.M.Eack, et al
Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial
Archives Of General Psychiatry…..Volume 67 #7……May 2010…..page 674 – 682